Dr. Tae Han Kim
Hak Cheol Shin
Pius S. Hornstein
Prognosis is less favorable in high-risk cases of chronic lymphocytic leukemia (CLL). Allogeneic hematopoietic cell transplantation (allo-HCT) has historically been the only treatment with a curative potential.
Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.
The 10 biggest healthcare companies in the world all climbed higher in the Forbes Global 2000 rankings for 2020.
Bayer researchers scrutinize the anonymized DNA of thousands of patients to find genetic differences so that they can gain a better understanding of the causes of cardiovascular diseases. The next step is to find active ingredients that can intervene in the disease processes.
BOSTON--(BUSINESS WIRE)--May 1, 2020-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization in the European Union for ULTOMIRIS® (ravulizumab) for the treat
THOUSAND OAKS, Calif., April 30, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2020 and discussed the company's response to the COVID-19 pandemic.
Many of the drugs and medicines that we rely on today are natural products taken from microbes like bacteria and fungi. Within these microbes, the drugs are made by tiny natural machines – mega-enzymes known as nonribosomal peptide synthetases (NRPSs).
Sales growth reflects strong underlying performance and additional impact from increased demand including stock building for many products
|1||Johnson & Johnson||United States|
|2||UnitedHealth Group||United States|
|3||CVS Health||United States|
|6||General Electric||United States|
Our world is changing. Whereas Great Britain ruled the waves in the 19th century, the US dominated the 20th century. And this 21st century? One thing is clear: China’s role becomes more and more important.
Michael Shanley, Director of Moller International, delivered a keynote speech at GHICC 2020
Daniel Ghinn, CEO of CREATION.co, delivered a speech at GHICC 2020
Mario Schäfer, Manager Portfolio Management Generics, Established Product at Sanofi Aventis Deutschland GmbH and Managing Director of Azeta Pharma GmbH, delivered a keynote speech at GHICC 2020
Professor Robert ZOREC，Member Academia Europaea (Lond.) & currently Vice-President Slovenian Academy of Sciences and Arts, delivered a keynote speech at GHICC 2020
He Mengsheng, Senior Advisor to Bayer, Former Vice President of Bayer Greater China, delivered a keynote speech at GHICC 2020
The event attracted approximately 300 people of more than 61 countries and regions from the Fortune Global 500, Forbes Global 2000, Global Health Industry Top 100, global top 100 industrial investors, national academies of science, world famous universities, emerging enterprises in health industry,
Zheng Xiongwei, Famous International Economist, Global Executive Chairman of APCEO, published the Cooperation Information of Global Health Industry Top 100
The conference main participants: Global Health Industry Leaders - Politicians, Government Officials, CEOs, Industry Giants, Science and Technology Experts, Academicians, Scientists and International Health Industry Investors, etc.
Global Health Industry Cooperation Conference - Leaders' Online Video Summit 2020 was initiated by Asia Pacific CEO Association, hosted by The People’s Government of Zhejiang Province, and organized by Asia Pacific CEO Association, Department of Commerce of Zhejiang Province, and Health Commission o